The Growing Problem of Peripheral Neuropathy in Prediabetes
Early intervention is essential to treating neuropathy in those with prediabetes.
All articles by John Schieszer, MA
Induced Pluripotent Stem Cells: New Tool for Studying Insulin Resistance
Induced pluripotent stem cells offer a new way to study insulin resistance and other metabolic disorders in humans.
Reflecting on 50 Years of Diabetes Research, Management
During the past 50 years, diabetes research and management has come a long way, although there is still work to be done.
Glycemic Extremes Impact Brain Function in Teens With Type 1 Diabetes
Activity in certain brain regions of teenagers with type 1 diabetes was increased or decreased with hyperglycemia and hypoglycemia.
Novel Super Long-Acting Insulin, GLP-1 Receptor Agonist Show Promise in Diabetes
PE0139, a super long-acting basal insulin, and PB1023, a weekly GLP-1 receptor agonist, may lead to novel approach to treating diabetes.
Unsupervised Closed Loop Insulin Delivery Feasible for Teens
Unsupervised closed loop insulin delivery is safe and feasible in the home setting in teens with type 1 diabetes.
Liraglutide May Reduce Postprandial Hyperglycemia in Closed Loop Setting
Adding liraglutide to insulin in a closed loop system may reduce postprandial hyperglycemia as well as insulin requirements, compared with insulin monotherapy.
Mothers’ Obesity May Pre-Program Children for Obesity, Metabolic Disease
Children may have a higher risk for fat accumulation and insulin resistance if their mothers were obese.
Food Insecurity Affects Diabetes Control in Latino Patients
Food insecurity has an impact on glycemic control and vegetable consumption in Latino patients with diabetes.
FLAT-SUGAR: GLP-1 Agonist Reduced Glycemic Variability Without Changing HbA1c
GLP-1 receptor agonist may be able to reduce glycemic variability rather than a prandial insulin.
Next post in ADA 75th Scientific Sessions 2015
